Literature DB >> 9671759

Myocyte proliferation in end-stage cardiac failure in humans.

J Kajstura1, A Leri, N Finato, C Di Loreto, C A Beltrami, P Anversa.   

Abstract

Introduced several decades ago, the dogma persists that cardiac myocytes are terminally differentiated cells and that division of muscle cells is impossible in the adult heart. More recently, nuclear mitotic divisions in myocytes occasionally were seen, but those observations were challenged on the assumption that the rate of cell proliferation was inconsequential for actual tissue regeneration. Moreover, mitoses were never detected in normal myocardium. However, the analysis of routine histologic preparations constituted the basis for the belief that myocytes were unable to reenter the cell cycle and divide, ignoring the limitations of these techniques. We report here by confocal microscopy that 14 myocytes per million were in mitosis in control human hearts. A nearly 10-fold increase in this parameter was measured in end-stage ischemic heart disease (152 myocytes per million) and in idiopathic dilated cardiomyopathy (131 myocytes per million). Because the left ventricle contains 5.8 x 10(9) myocytes, these mitotic indices imply that 81.2 x 10(3), 882 x 10(3), and 760 x 10(3) myocytes were in mitosis in the entire ventricular myocardium of control hearts and hearts affected by ischemic and idiopathic dilated cardiomyopathy, respectively. Additionally, mitosis lasts less than 1 hr, suggesting that large numbers of myocytes can be formed in the nonpathologic and pathologic heart with time. Evidence of cytokinesis in myocytes was obtained, providing unequivocal proof of myocyte proliferation.

Entities:  

Mesh:

Year:  1998        PMID: 9671759      PMCID: PMC21157          DOI: 10.1073/pnas.95.15.8801

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Left ventricular hypertrophy: a cytometric study on 42 human hearts.

Authors:  E Astorri; R Bolognesi; B Colla; A Chizzola; O Visioli
Journal:  J Mol Cell Cardiol       Date:  1977-09       Impact factor: 5.000

Review 2.  Death by design. Programmed cell death in cardiovascular biology and disease.

Authors:  W R MacLellan; M D Schneider
Journal:  Circ Res       Date:  1997-08       Impact factor: 17.367

3.  Biochemical correlates of cardiac hypertrophy. IV. Observations on the cellular organization of growth during myocardial hypertrophy in the rat.

Authors:  D Grove; R Zak; K G Nair; V Aschenbrenner
Journal:  Circ Res       Date:  1969-10       Impact factor: 17.367

4.  Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice.

Authors:  M H Soonpaa; L J Field
Journal:  Am J Physiol       Date:  1994-04

5.  Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart.

Authors:  G Olivetti; E Cigola; R Maestri; D Corradi; C Lagrasta; S R Gambert; P Anversa
Journal:  J Mol Cell Cardiol       Date:  1996-07       Impact factor: 5.000

6.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

Authors:  W C Roberts; R J Siegel; B M McManus
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

7.  Hypertrophy or hyperplasia in cardiac muscle. Post-mortem human morphometric study.

Authors:  S Grajek; M Lesiak; M Pyda; M Zajac; S Paradowski; E Kaczmarek
Journal:  Eur Heart J       Date:  1993-01       Impact factor: 29.983

8.  Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

Authors:  C A Beltrami; N Finato; M Rocco; G A Feruglio; C Puricelli; E Cigola; F Quaini; E H Sonnenblick; G Olivetti; P Anversa
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

9.  Gender differences and aging: effects on the human heart.

Authors:  G Olivetti; G Giordano; D Corradi; M Melissari; C Lagrasta; S R Gambert; P Anversa
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

10.  Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans.

Authors:  G Olivetti; M Melissari; T Balbi; F Quaini; E H Sonnenblick; P Anversa
Journal:  J Am Coll Cardiol       Date:  1994-07       Impact factor: 24.094

View more
  117 in total

1.  Contribution of de novo protein synthesis to the hypertrophic effect of IGF-1 but not of thyroid hormones in adult ventricular cardiomyocytes.

Authors:  D Bell; B J McDermott
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Normal lactational environment restores cardiomyocyte number after uteroplacental insufficiency: implications for the preterm neonate.

Authors:  M Jane Black; Andrew L Siebel; Oksan Gezmish; Karen M Moritz; Mary E Wlodek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-07       Impact factor: 3.619

3.  Cardioprotective effects of transthoracic microelectrostimulation.

Authors:  E P Kharchenko; M N Klimenko
Journal:  Dokl Biol Sci       Date:  2002 May-Jun

4.  A matter of life and death: cardiac myocyte apoptosis and regeneration.

Authors:  Bernardo Nadal-Ginard; Jan Kajstura; Piero Anversa; Annarosa Leri
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 5.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 6.  Autologous stem cells for functional myocardial repair.

Authors:  Yitzhack Schwartz; Ran Kornowski
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

7.  Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host.

Authors:  Bertrand Leobon; Isabelle Garcin; Philippe Menasche; Jean-Thomas Vilquin; Etienne Audinat; Serge Charpak
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-12       Impact factor: 11.205

8.  Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy.

Authors:  Konrad Urbanek; Federico Quaini; Giordano Tasca; Daniele Torella; Clotilde Castaldo; Bernardo Nadal-Ginard; Annarosa Leri; Jan Kajstura; Eugenio Quaini; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-19       Impact factor: 11.205

9.  Partial reversion of left ventricle remodeling in cardiomyopathy patients by means of transthoracic microelectrostimulation.

Authors:  E P Kharchenko; G G Khubulava; V B Pyr'ev; M N Klimenko
Journal:  Dokl Biol Sci       Date:  2001 Sep-Oct

10.  The human heart: a self-renewing organ.

Authors:  Jan Kajstura; Toru Hosoda; Claudia Bearzi; Marcello Rota; Silvia Maestroni; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.